1. Pink Sheet

Barrier For Applying AI To Precision Medicine: Drug Industry Reluctance To Share Data

 
• By Brenda Sandburg

Eric Topol says there is not enough regulatory teeth to require companies to share data with the medical community. Experts at a workshop on the application of artificial intelligence and machine learning for precision medicine also want data and algorithms to be accessible.

AI data
Experts noted the challenges of using artificial intelligence for precision medicine. • Source: Shutterstock

As the US Food and Drug Administration and pharmaceutical industry focus on using artificial intelligence and machine learning in drug development, access to the data and algorithms used in the field remains one of the biggest challenges.

At a 17 February workshop on "Application of AI and Machine Learning for Precision Medicine," Eric Topol, founder and director of Scripps Research Translational Institute, said companies do not want to make their data and algorithms

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from AI

More from Advanced Technologies